Accelus President & Chief Executive Officer Kevin McGann Kevin McGann, Accelus President & CEO, has been named to the company's…
Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue…
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…
LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company…
- Amendment of commercial and regulatory milestones for $50 million of additional non-dilutive capital to support launch of Motiva Implants®…
- Amendment of commercial and regulatory milestones for $50 million of additional non-dilutive capital to support launch of Motiva Implants®…
Received Notice of Allowance from the USPTO on February 15, 2024LOS GATOS, CA / ACCESSWIRE / February 22, 2024 /…
Raises Approximately $2.6 Million in Gross ProceedsRetires $1.25 Million in Secured DebtThis corrects and replaces the headline in the release…
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter and full year ended…
~ Raises Approximately $2.6 Million in Gross Proceeds ~~ Retires $1.25 Million in Secured Debt ~LOS GATOS, CA / ACCESSWIRE…